Development and application of dedicated positron emission tomography (PET) systems in prostate cancer diagnostics
| Main Authors: | Wędrowski, Mateusz, Maruszak, Marta, Wędrowska, Ewelina, Piskorska, Elżbieta, Małkowski, Bogdan |
|---|---|
| Format: | Article |
| Terbitan: |
, 2017
|
| Online Access: |
https://zenodo.org/record/1039884 |
Daftar Isi:
- Wędrowski Mateusz, Maruszak Marta, Wędrowska Ewelina, Piskorska Elżbieta, Małkowski Bogdan. Development and application of dedicated positron emission tomography (PET) systems in prostate cancer diagnostics. Journal of Education, Health and Sport. 2017;7(8):1206-1220. eISSN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.1039884 http://ojs.ukw.edu.pl/index.php/johs/article/view/4930 The journal has had 7 points in Ministry of Science and Higher Education parametric evaluation. Part B item 1223 (26.01.2017). 1223 Journal of Education, Health and Sport eISSN 2391-8306 7 © The Authors 2017; This article is published with open access at Licensee Open Journal Systems of Kazimierz Wielki University in Bydgoszcz, Poland Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited. This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited. The authors declare that there is no conflict of interests regarding the publication of this paper. Received: 05.08.2017. Revised: 10.08.2017. Accepted: 31.08.2017. Development and application of dedicated positron emission tomography (PET) systems in prostate cancer diagnostics Mateusz Wędrowski1,2, Marta Maruszak1,2, Ewelina Wędrowska3, Elżbieta Piskorska4, Bogdan Małkowski1,2 1Department of Positron Emission Tomography and Molecular Diagnostics, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland 2Nuclear Medicine Department, Oncology Centre, Bydgoszcz, Poland 3Department of Gene Therapy, Faculty of Medicine, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland 4Department of Pathobiochemistry and Clinical Chemistry, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland Summary Introduction: One of the most important parameter in prostate cancer diagnostics is fast and accurate diagnosis. The important role plays finding cancer markers in blood but also advanced medical imaging systems technology, that allows for faster and more efficient objects projection. There are ongoing efforts to develop new multimodal imaging systems and find new PET radiopharmaceuticals. Aim of the study: The aim of this study is presentation of chosen information about dedicated PET systems in fusion with US and description of the most important PET radiopharmaceuticals for prostate cancer diagnosis that could confirm the meaning of new imaging technologies. Short description of state of knowledge: The most interesting recent scientific trends in prostate cancer medical imaging is presented in this work. Discussion is based on grant projects under realization. Potential clinical application problems were analyzed. The motivation of these projects was explained. Advantages and drawbacks of most recent radiopharmaceuticals for prostate cancer diagnosis was also discussed. Summation: New ideas in prostate cancer therapy are based on replacement the blind biopsy with guided biopsy in new meaning. Advanced medical imaging technology and application of new PET radiotracers in Poland (– the country with high ageing factor) may allow for cancer slowdown in early stage and minimize the treatment costs. Key words: cancer, diagnostics, indicators, PET, prostate, radiopharmaceutics